Sky Century Investment (SKYI) Cash from Financing Activities (2012 - 2026)
Sky Century Investment (SKYI) reported Cash from Financing Activities of $710.0 for Q1 2026, down 97.15% year-over-year from $24917.0 in Q1 2025, and down 97.07% quarter-over-quarter from $24200.0 in Q4 2025.
Sky Century Investment (SKYI) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 6 years of Cash from Financing Activities data on file, last reported at $710.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $710.0, down 97.15% year-over-year; the trailing twelve-month figure through Feb 2026 was $35302.0 (down 34.8% YoY), and the FY2025 annual result was $46136.0, up 59.08% from the prior year.
- Cash from Financing Activities eased to $710.0 in Q1 2026 per SKYI's latest filing, from $24200.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $24917.0 in Q1 2025 and troughed at $710.0 in Q1 2026.
- A 3-year average of $12778.4 and a median of $10827.0 in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities soared 123.52% in 2025, then sank 97.15% in 2026.
- A 3-year view of Cash from Financing Activities shows it stood at $10827.0 in 2024, then soared by 123.52% to $24200.0 in 2025, then tumbled by 97.07% to $710.0 in 2026.
- Business Quant data shows SKYI's Cash from Financing Activities at $710.0 in Q1 2026, $24200.0 in Q4 2025, and $10392.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Sky Century Investment | - | - | 31,666.00 | 710.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 710.00 |
| Feb 28, 2026 | 710.00 |
| Nov 30, 2025 | 24,200.00 |
| Nov 30, 2025 | 24,200.00 |
| May 31, 2025 | 10,392.00 |
| May 31, 2025 | 10,392.00 |
| Feb 28, 2025 | 24,917.00 |
| Feb 28, 2025 | 24,917.00 |
| Nov 30, 2024 | 10,827.00 |
| Nov 30, 2024 | 10,827.00 |
| Aug 31, 2024 | 12,510.00 |
| Aug 31, 2024 | 12,510.00 |
| May 31, 2024 | 5,893.00 |
| May 31, 2024 | 5,893.00 |
| May 31, 2014 | 1,130.00 |
| May 31, 2014 | 1,130.00 |
| Nov 30, 2013 | 10,350.00 |
| Nov 30, 2013 | 10,350.00 |
| Aug 31, 2013 | 9,700.00 |
| Aug 31, 2013 | 9,700.00 |